PRODUCTS & INNOVATION
Read why Barron's predicts strong growth for Abbott shareholders.
Feb 23 2017
By investing in areas that are aligned with healthcare trends, Abbott is well-positioned for growth for many years to come. In fact, in a recent Barron’s article, the publication noted that "with a 2.5% dividend included, [Abbott] could provide a 20% total return within 12 months."
Click to read more from Barron's and see what Abbott Chairman and CEO Miles D. White and others had to say about the company in 2017.
Improving Lives Through Better Nutrition
Rapid Diagnostics Builds for Its Future
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.